Experts discuss PPI use for GI protection in patients on antithrombotics, highlighting risk factors, dosing, drug ...

Blackstone Life Sciences and Anthos Therapeutics, Inc. (“Anthos” or the “company”), a transformative, clinical-stage biopharmaceutical company developing innovative therapies for the treatment of ...

Longevity is increasing worldwide, and Dr Ray O’Connor takes a look at some of the most recent clinical studies on the subject of gerontology ...

A systematic review and meta-analysis estimating the differences in bleeding risks between therapeutic-dose non-vitamin K oral anticoagulants (NOACs) and single antiplatelet therapy (aspirin) found ...

More than 60,000 people bleed to death every year in the United States. Many of those deaths occur before the patient reaches ...

The doctor who caused the death of singer Shin Hae-chul through medical malpractice was sentenced to prison and detained in ...

Hisashi Ouchi, 35, experienced unimaginable suffering in an 83-day ordeal after being exposed to a record-breaking amount of ...

A new report shows that almost half of the adults in the US aren't aware of the latest health guidelines around aspirin, which claim the risks of a daily low-dose aspirin outweigh the benefits. This ...

Queensland has the third highest prevalence of a debilitating bowel disease that impacts 180,000 Australians, costing ...

Turmeric and honey contain beneficial compounds that can help reduce inflammation, improve metabolic health, and aid in weight loss.

About Abelacimab Abelacimab is a novel, investigational, highly selective, fully human monoclonal antibody that binds tightly to Factor XI to block its activation and prevent the generation of the ...